Haleon Plc’s (NYSE:HLN) fiscal year 2023 revenues increased 4.1% Y/Y to £11.3 billion, equivalent to around $14.03 billion, missing the consensus of $14.47 billion.
Revenue grew 8.0% organically for FY 2023, with 7.0% price and 1.0% volume/mix, the company reported on Thursday.
The FTSE 100-listed business was spun out from GSK plc (NYSE:GSK).
FX reduced revenue by 3.8%, and M&A impact was (0.1)%.
Adjusted operating profit increased 10.4% constant currency to £2.55 billion; Excluding M&A impact, adjusted operating profit was up 10.8% constant currency, with a margin of 22.6%, up 50bps.
Adjusted diluted EPS 17.3p, down 6.0%, mainly …